ACT-GLOBAL Adaptive Platform Trial for Stroke — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

ACT-GLOBAL Adaptive Platform Trial for Stroke — Stella

View on ClinicalTrials.gov

Recruiting

Back to Stroke trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(2 sites)

Australia

The George Institute for Global Health, Sydney, New South Wales

Canada

University of Calgary, Calgary, Alberta

Key details

Phase

Large-scale testing

Sponsor

The George Institute

Collaborators

University of Calgary, Berry Consultants

Enrollment target

~20,000 participants

Started

September 2024

Primary completion

September 2034

Age range

18 Years and older

Last updated November 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.